Walleye Trading’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-38,031
Closed -$485K 5366
2022
Q3
$499K Sell
38,031
-25,172
-40% -$372K ﹤0.01% 2903
2022
Q2
$883K Buy
+63,203
New +$845K ﹤0.01% 2351
2021
Q4
Sell
-6,473
Closed -$91.6K 5807
2021
Q3
$95K Sell
6,473
-5,655
-47% -$95.5K ﹤0.01% 4388
2021
Q2
$221K Buy
12,128
+2,858
+31% +$50.9K ﹤0.01% 3817
2021
Q1
$161K Buy
+9,270
New +$163K ﹤0.01% 3813
2020
Q1
Sell
-14,821
Closed -$316K 4482
2019
Q4
$316K Buy
14,821
+6,010
+68% +$135K ﹤0.01% 2773
2019
Q3
$202K Buy
8,811
+7,926
+896% +$169K ﹤0.01% 2912
2019
Q2
$17K Buy
+885
New +$17.2K ﹤0.01% 3771
2019
Q1
Sell
-50,733
Closed -$961K 4699
2018
Q4
$836K Buy
50,733
+40,945
+418% +$824K 0.01% 1915
2018
Q3
$226K Buy
+9,788
New +$222K ﹤0.01% 3658
2015
Q4
Sell
-21,429
Closed -$497K 5632
2015
Q3
$497K Buy
+21,429
New +$547K ﹤0.01% 1560

Other funds holding SBRA

Walleye Trading's SBRA Position: Q4 2022 in Review

Walleye Trading sold out of Sabra Healthcare REIT (SBRA) in Q4 2022, closing a stake of 38,031 shares — an estimated $485K sold.

Walleye Trading first reported a position in SBRA in Q3 2015 and held it in 11 quarters. The position peaked at $883K in Q2 2022. 327 funds tracked by Wall St. Rank hold SBRA as of Q4 2022.

  • Walleye Trading reported no remaining Sabra Healthcare REIT position as of Q4 2022 after selling out during the quarter.
  • Walleye Trading sold 38,031 Sabra Healthcare REIT shares in Q4 2022, an estimated $485K.
  • Walleye Trading first reported a position in Sabra Healthcare REIT in Q3 2015 and held it in 11 quarters.
  • Walleye Trading's Sabra Healthcare REIT position peaked at $883K in Q2 2022.
  • 327 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.